uurimisrühmad - Stabilis 4.0

viimane versioon :
19/11/2024

uurimisrühmad - Hôpital Robert Debré, Service pharmacie

Hôpital Robert Debré, Service pharmacie

Paris

Viited

(7)

Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/mL ursodesoxycholic acid for newborns.
Hausherr A, Roessle C, Pinet E, Vasseur V, Abarou T, Benakouche S, Bourdon O, Storme T. (olivier.bourdon@aphp.fr)
Pharmaceutical Technology in Hospital Pharmacy - 2020 -

Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method.
Bonnet M, Dermu M, Roessle C, Bellaiche M, Abarou T, Vasseur V, Benakouche S, Storme T. (mathildb@hotmail.fr)
Pharmaceutical Technology in Hospital Pharmacy - 2018 -

Stability and sterility of meglumine gadoterate injection repackaged in plastic syringes.
Micard S, Rieutord A, Prognon P, Hassan M, Brion F. ()
Int J Pharm - 2001 - ; 212: 93-99.

Stability and compatibility of an aerosol mixture including N-acetylcysteine, netilmicin and betamethasone
Rieutord A, Arnaud P, Dauphin JF, Brion F. ()
Int J Pharm - 1999 - ; 190, 1: 103-107.

Stability and compatibility study of a carboplatin solution in syringes for continuous ambulatory infusion.
Valière C, Arnaud P, Caroff E, Dauphin JF, Clément G, Brion F. ()
Int J Pharm - 1996 - ; 138: 125-128.

Stability and compatibility of 2.5 mg/ml methotrexate solution in plastic syringes over 7 days.
Jacolot A, Arnaud P, Lecompte D, Alamercery S, Caroff E, Naveau C, Guillot T, Bousselet M, Brion F. ()
Int J Pharm - 1996 - ; 128: 283-286.

molekulid uuritud

(9)

		Betamethasone sodium phosphate
		Budesonide
		Carboplatin
		Gadoterate meglumine
		Ioxitalamate sodium
		Methotrexate sodium
		N-acetylcysteine
		Netilmicin sulfate
		Ursodesoxycholique acid

Mentions Légales